Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 25Ovarian Neoplasms 19Neoplasms 12Fallopian Tube Neoplasms 12Carcinoma, Hepatocellular 11Endometrial Neoplasms 7Neoplasm Metastasis 6Colonic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Glioblastoma 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Lung Neoplasms 3Liver Neoplasms 3Digestive System Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Mouth Neoplasms 2Lymphoid Interstitial Pneumonia 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Brenner Tumor 2Breast Neoplasms 2Biliary Tract Neoplasms 2Astrocytoma 2

Interventions

trifluridine tipiracil drug combination 1HMPL-013 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Cancer Metastatic × Bevacizumab × 30 days × Clear all
NCT04564898 2026-05-20

TriComB

Gruppo Oncologico del Nord-Ovest

Phase 1/2 Active not recruiting
48 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡